Publications by authors named "Brian Henick"

Claim this Profile
E
Editorial: Nature and nurture in early onset lung cancer.
Ilit Turgeman, Brian S Henick, Laura Mezquita

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrophobic complementarity-determining region 3 (CDR3) sequences elucidate the cardiotoxic effects of immune checkpoint inhibitors.
Shoiab Bukhari, Rajat Mohindra, Matthieu Paiola, Carly Tymm, Robert Winchester, Brian S Henick

Res Sq· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer.
Lanyi Nora Chen, Xin Ma, Benjamin Herzberg, Brian S Henick, Anup K Biswas

Oncologist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of eligibility criteria on KRASG12C inhibitor trials in patients with NSCLC.
Margaux Wooster, Michael May, Prashasti Agrawal, Jonathan Lee, Benjamin May, Brian S Henick

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late Metastases.
Michelle Garlin Politis, Mahesh Mansukhani, Benjamin O Herzberg, Lanyi N Chen, Mark Stoopler, Brian S Henick

J Pers Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.
Breelyn A Wilky, Gary K Schwartz, Michael S Gordon, Anthony B El-Khoueiry, Andrea J Bullock, Brian Henick

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases.
Somnath Tagore, Lindsay Caprio, Amit Dipak Amin, Kresimir Bestak, Karan Luthria, Brian S Henick

Nat Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoarthritis increases the risk of inflammatory arthritis due to immune checkpoint inhibitors associated with tissue-resident memory T cells.
Matthieu Paiola, Daniel M Portnoy, Luke Yi Hao, Shoiab Bukhari, Robert J Winchester, Brian S Henick

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy.
Brian S Henick, Alison M Taylor, Hiroshi Nakagawa, Kwok-Kin Wong, J Alan Diehl

Cancer Cell· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
Juanita Lopez, Thomas Powles, Fadi Braiteh, Lillian L Siu, Patricia LoRusso, Brian S Henick

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational inhalable extracellular vesicle-based mRNA therapy for the treatment of lung cancer.
Mengrui Liu, Brian Henick, Ke Cheng

Clin Transl Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings.
Brian S Henick, Peter D Koch, Justin F Gainor, Mark M Awad, Codruta Chiuzan

J Immunother Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma.
Sejal Jain, Xuechun Bai, Samyukta Mallick, Branden Kinghorn, Benjamin May, Brian S Henick

JCO Precis Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancements in TGF-β Targeting Therapies for Head and Neck Squamous Cell Carcinoma.
William R Britton, Isabel Cioffi, Corinne Stonebraker, Matthew Spence, Ogoegbunam Okolo, Brian Henick

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAPping Into PD-L1 Testing Efficiency for Gastroesophageal Cancer.
Brian S Henick, Ryan H Moy

JCO Precis Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmaticism in Cancer Clinical Trials.
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, Brian S Henick, Wade T Iams

Am Soc Clin Oncol Educ Book· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled Chaos: Parsing Acquired Immunoresistance in Lung Cancer.
Brian S Henick, Benjamin O Herzberg, Carla P Concepcion-Crisol, Alison M Taylor

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results.
Amy R Rappaport, Chrisann Kyi, Monica Lane, Meghan G Hart, Melissa L Johnson, Brian S Henick

Nat Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles.
Xiao Cheng, Brian S Henick, Ke Cheng

ACS Nano· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity.
Xizi Hu, Shoiab M Bukhari, Carly Tymm, Kieran Adam, Shalom Lerrer, Brian S Henick

J Immunother Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis.
Johanna Straube, Shoiab Bukhari, Shalom Lerrer, Robert J Winchester, Yevgeniya Gartshteyn, Brian S Henick

Arthritis Res Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials.
Laurent Dercle, Melissa Yang, Mithat Gönen, Jessica Flynn, Chaya S Moskowitz, Brian S Henick

Eur Radiol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis.
Johanna Straube, Shoiab Bukhari, Shalom Lerrer, Robert Winchester, Brian Henick

bioRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma.
Karen J Dunbar, Tatiana A Karakasheva, Qiaosi Tang, Gizem Efe, Eric W Lin, Brian Henick

Mol Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
Prabhjot S Mundi, Filemon S Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Brian S Henick

Cancer Discov· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis